Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.

Benjamin BergerTilman HottenrottSebastian RauerOliver Stich

Published in: BMC neurology (2017)

Our data suggest that there is no need to routinely screen anti-AQP4 antibody positive NMOSD patients with a typical presentation for onconeural antibodies. Furthermore, absence of these antibodies in NMOSD, which is typically non-paraneoplastic, confirms their high specificity for PNS.

Keyphrases

electronic health record
high throughput
big data
machine learning
single cell
data analysis